What is Imio?
Imio operates at the intersection of sustainable agriculture and biotechnology, focusing on the development of high-efficiency biological products. The company's flagship innovation, Re-Gen, serves as a transformative tool for modern farming by converting crop residue into bioavailable nutrients. By providing a potent alternative to conventional chemical fertilizers, Imio addresses the dual challenge of increasing crop yields while simultaneously reducing the environmental footprint of large-scale agricultural operations. Their technology is engineered for versatility, ensuring consistent performance across diverse soil profiles and climatic conditions, which positions the company as a critical player in the global transition toward regenerative agriculture.
How much funding has Imio raised?
Imio has raised a total of $6M across 1 funding round:
Private Equity
$6M
Private Equity (2026): $6M, investors not publicly disclosed
Key Investors in Imio
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for Imio?
With this major enterprise-level funding, Imio is poised to transition from a high-growth startup to a dominant force in the agricultural inputs market. The strategic roadmap likely involves scaling manufacturing capabilities to meet rising demand and expanding distribution networks to reach key agricultural hubs globally. Furthermore, the capital will support ongoing research and development efforts to refine their microbial formulations, ensuring that Imio remains at the forefront of the bio-fertilizer sector. As the industry shifts toward sustainable productivity, Imio's focus on cost-effective, environmentally conscious solutions provides a robust foundation for long-term commercial viability and market leadership.
See full Imio company page
